Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer

Seung Woo Han, D-Y. Oh, S-A Im, +11

British Journal of Cancer

LBA7_PR Nivolumab plus chemotherapy versus chemotherapy alone in patients with previously untreated advanced or recurrent gastric/gastroesophageal junction (G/GEJ) cancer: ATTRACTION-4 (ONO-4538-37) study

Narikazu Boku, M.-H. Ryu, D-Y. Oh, +16

Annals of Oncology

Chemotherapy Versus ChemotherapyGastrointestinal OncologyMedicineGastroenterologyPathology +6

Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (KCSG-BR15-10): a multicentre, open-label, randomised, phase 2 trial

Yeon Hee Park, Tae‐Yong Kim, Gun Min Kim, +60

The Lancet Oncology

Breast OncologyMedicinePharmacologyGynecologyBreast Cancer +6

High tumour islet macrophage infiltration correlates with improved patient survival but not with EGFR mutations, gene copy number or protein expression in resected non-small cell lung cancer

Dae‐Wi Kim, Hanbo Min, Kelvin H. Lee, +12

British Journal of Cancer

LBA73 Pathological complete response (pCR) to durvalumab plus 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in resectable gastric and gastroesophageal junction cancer (GC/GEJC): Interim results of the global, phase III MATTERHORN study

Yelena Y. Janjigian, S-E. Al-Batran, Zev A. Wainberg, +17

Annals of Oncology

Tumor BiologySurgical OncologyOncologyEsophageal CancerGastrointestinal Oncology +11

VP1-2023: Pembrolizumab (pembro) plus chemotherapy (chemo) as first-line therapy for advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) cancer: Phase III KEYNOTE-859 study

Sun Young Rha, L.S. Wyrwicz, P.E. Yanez Weber, +17

Annals of Oncology

First-line TherapyEsophageal CancerGastroesophageal JunctionAdvanced Her2-negative GastricMedicine +6

Molecular cloning, pharmacological characterization, and histochemical distribution of frog vasotocin and mesotocin receptors

Sujata Acharjee, J.-C. Do-Rego, D-Y. Oh, +6

Journal of Molecular Endocrinology

The beneficial effect of palliative resection in metastatic colorectal cancer

Jung‐Hyun Park, Tae‐Yop Kim, KH Lee, +10

British Journal of Cancer

Prognostic implication of mucinous histology in colorectal cancer patients treated with adjuvant FOLFOX chemotherapy

Lee Dw, Sang-Woong Han, H-J. Lee, +12

British Journal of Cancer

1916P Larotrectinib treatment of advanced TRK fusion thyroid cancer

Maria E. Cabanillas, Alexander Drilon, Anna F. Farago, +17

Annals of Oncology

MedicineThyroid DiseaseLarotrectinib TreatmentCancer TreatmentOncology +2